Influence of cyclodextrin complexation on the in vitro permeation and skin metabolism of dexamethasone

被引:62
作者
Lopez, RFV
Collett, JH
Bentley, MVLB
机构
[1] Univ Sao Paulo, Fac Pharmaceut Sci Ribeirao Preto, BR-14040903 Ribeirao Preto, Brazil
[2] Univ Manchester, Dept Pharm, Manchester M13 9PL, Lancs, England
基金
巴西圣保罗研究基金会;
关键词
inclusion complexes; cyclodextrin; in vitro skin permeation; skin metabolism;
D O I
10.1016/S0378-5173(00)00365-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The influence of complexation of a model drug, dexamethasone acetate (DMA), with beta-cyclodextrin (beta-CyD) and hydroxypropyl- beta-cyclodextrin (HP-beta-CyD) on the in vitro permeation through hairless mouse skin and on skin metabolism have been investigated. Complexation with CyDs increased the amount of DMA permeated in the order of 2.0 and 3.0 times for beta-CyD and HP-beta-CyD, respectively. The partition coefficient, between stratum corneum and buffer (K-SC/buffer), for DMA decreased when the drug was an inclusion complex, being greatest for DMA/HP-beta-CyD complex. Complexation protected the drug against skin metabolism. The increase of skill permeation and stability of the model drug in the skin suggest that the complexation with beta-CyD and HP-beta-CyD is a rational way to improve the physical-chemical properties of drugs for use in transdermal delivery systems. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:127 / 132
页数:6
相关论文
共 14 条
[1]   Enhancing effect of hydroxypropyl-β-cyclodextrin on cutaneous penetration activation of ethyl 4-biphenylyl acetate in hairless mouse skin [J].
Arima, H ;
Miyaji, T ;
Irie, T ;
Hirayama, F ;
Uekama, K .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 1998, 6 (01) :53-59
[2]  
Arima H, 1996, CHEM PHARM BULL, V44, P582
[3]  
Barry, 1983, DERMATOLOGICAL FORMU
[4]   Influence of solubility and permeant size on absorption and metabolism of xenobiotics in rabbit skin [J].
Bast, GE .
HUMAN & EXPERIMENTAL TOXICOLOGY, 1997, 16 (08) :435-440
[5]   Effects of beta-cyclodextrins on skin: Implications for the transdermal delivery of piribedil and a novel cognition enhancing-drug, S-9977 [J].
Legendre, JY ;
Rault, I ;
Petit, A ;
Luijten, W ;
Demuynck, I ;
Horvath, S ;
Ginot, YM ;
Cuine, A .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 1995, 3 (06) :311-322
[6]   Study of beta-cyclodextrin and ethylated beta-cyclodextrin salbutamol complexes, in vitro evaluation of sustained-release behaviour of salbutamol [J].
LemesleLamache, V ;
Wouessidjewe, D ;
Cheron, M ;
Duchene, D .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1996, 141 (1-2) :117-124
[7]   Cyclodextrins as permeation enhancers:: some theoretical evaluations and in vitro testing [J].
Másson, M ;
Loftsson, T ;
Másson, G ;
Stefánsson, E .
JOURNAL OF CONTROLLED RELEASE, 1999, 59 (01) :107-118
[8]   TRANSDERMAL DELIVERY OF DRUGS WITH DIFFERING LIPOPHILICITIES USING AZONE ANALOGS AS DERMAL PENETRATION ENHANCERS [J].
PHILLIPS, CA ;
MICHNIAK, BB .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1995, 84 (12) :1427-1433
[9]   TRANSDERMAL DRUG TRANSPORT AND METABOLISM .2. THE ROLE OF COMPETING KINETIC EVENTS [J].
POTTS, RO ;
MCNEILL, SC ;
DESBONNET, CR ;
WAKSHULL, E .
PHARMACEUTICAL RESEARCH, 1989, 6 (02) :119-124
[10]  
Sapan CV, 1999, BIOTECHNOL APPL BIOC, V29, P99